Skip to main content
SpringerLink
Log in
Book cover

Clinical Ophthalmic Oncology pp 189–200Cite as

Uveal Malignant Melanoma – Management Options: Proton Beam Radiotherapy

  • Chapter
  • First Online:

  • 815 Accesses

Abstract

Radiotherapy (RT) is the standard of care for the vast majority of malignant melanomas of the uveal tract. Eye conservation and, in many cases, maintenance of useful vision are possible.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Nag S, Quivey JM, Earle JD, Followill D. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys. 2003;56(2):544–55.

    Article  PubMed  Google Scholar 

  2. Gragoudas ES, Goitein M, Koehler A, et al. Proton irradiation of choroidal melanomas: preliminary results. Arch Ophthalmol. 1978;96(9):1583–91.

    Article  Google Scholar 

  3. Char DH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 1998;125(1):81–9.

    Article  CAS  PubMed  Google Scholar 

  4. Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990;97(6):769–77.

    Article  CAS  PubMed  Google Scholar 

  5. Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology. 2003;110(11):2223–34.

    Article  PubMed  Google Scholar 

  6. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001;119(7):969–82.

    Article  CAS  PubMed  Google Scholar 

  7. Gragoudas E, Goitein M, Seddon J, et al. Preliminary results of proton beam irradiation of macular and paramacular melanomas. Br J Ophthalmol. 1984;68(7):479–85.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study. Arch Ophthalmol. 1982;100(6):928–34.

    Article  CAS  PubMed  Google Scholar 

  9. Mueller AJ, Talies S, Schaller UC, Horstmann G, Wowra B, Kampik A. Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology. 2000;107(7):1381–7; discussion 87–8.

    Article  CAS  PubMed  Google Scholar 

  10. Haas A, Pinter O, Papaefthymiou G, et al. Incidence of radiation retinopathy after high-dosage single-fraction gamma knife radiosurgery for choroidal melanoma. Ophthalmology. 2002;109(5):909–13.

    Article  PubMed  Google Scholar 

  11. Suit HD, Goitein M, Tepper J, et al. Exploratory study of proton radiation therapy using large field techniques and fractionated dose schedules. Cancer. 1975;35(6):1646–57.

    Article  CAS  PubMed  Google Scholar 

  12. Suit H. The Gray lecture 2001: coming technological advances in radiation oncology. Int J Radiat Oncol Biol Phys. 2002;53(4):798–809.

    Article  PubMed  Google Scholar 

  13. Koehler A, Schneider R, Sisterson J. Range modulators for protons and heavy ions. Nucl Instrum Meth. 1975;131:437–40.

    Article  CAS  Google Scholar 

  14. Gragoudas ES. Charged particle irradiation of uveal melanoma. In: Ryan SJ, editor. Retina. 4th ed. Philadelphia: Mosby; 2006.

    Google Scholar 

  15. Goitein M, Miller T. Planning proton therapy of the eye. Med Phys. 1983;10(3):275–83.

    Article  CAS  PubMed  Google Scholar 

  16. Gragoudas ES. Charged particle irradiation of uveal melanoma. In: Ryan SJ, editor. Retina. 3rd ed. St. Louis: Mosby; 2001.

    Google Scholar 

  17. Gragoudas ES, Goitein M, Koehler A, et al. Proton irradiation of malignant melanoma of the ciliary body. Br J Ophthalmol. 1979;63(2):135–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Gragoudas E, Goitein M, Verhey L, et al. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology. 1980;87(6):571–81.

    Article  CAS  PubMed  Google Scholar 

  19. Gragoudas E, Seddon J, Egan K, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987;94(4):349–53.

    Article  CAS  PubMed  Google Scholar 

  20. Gragoudas ES, Lane AM, Regan S, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000;118(6):773–8.

    Article  CAS  PubMed  Google Scholar 

  21. Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys. 2001;51(1):138–47.

    Article  CAS  PubMed  Google Scholar 

  22. Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD. Proton radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys. 2005;62(5):1405–11.

    Article  PubMed  Google Scholar 

  23. Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys. 2006;65(3):780–7.

    Article  PubMed  Google Scholar 

  24. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002;120(12):1665–71.

    Article  PubMed  Google Scholar 

  25. Gragoudas E, Egan K, Seddon J, Walsh S, Munzenrider J. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology. 1992;99(5):760–6.

    Article  CAS  PubMed  Google Scholar 

  26. Marucci L, Lane AM, Li W, et al. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys. 2006;64(4):1018–22.

    Article  PubMed  Google Scholar 

  27. Harbour JW, Murray TG, Byrne SF, et al. Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina. 1996;16(2):129–34.

    Article  CAS  PubMed  Google Scholar 

  28. Lane AM, Kim IK, Gragoudas ES. Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011;128(9):1127–30.

    Article  Google Scholar 

  29. Sagoo MS, Shields CL, Mashayekhi A, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients. Arch Ophthalmol. 2008;126(11):1515–22.

    Article  PubMed  Google Scholar 

  30. Finger PT. Finger’s “slotted” eye plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumours. Br J Ophthalmol. 2007;91(7):891–4.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Sagoo MS, Shields CL, Mashayekhi A, et al. Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma). Arch Ophthalmol. 2007;125(9):1202–9.

    Article  PubMed  Google Scholar 

  32. Egan K, Ryan L, Gragoudas E. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: An example of regression on time-dependent covariates. Arch Ophthalmol. 1998;116(3):366–70.

    Article  CAS  PubMed  Google Scholar 

  33. Egger E, Zografos L, Schalenbourg A, et al. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys. 2003;55(4):867–80.

    Article  PubMed  Google Scholar 

  34. Fuss M, Loredo LN, Blacharski PA, Grove RI, Slater JD. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys. 2001;49(4):1053–9.

    Article  CAS  PubMed  Google Scholar 

  35. Saornil M, Egan K, Gragoudas E, Seddon J, Walsh S, Albert D. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992;110(8):1112–8.

    Article  CAS  PubMed  Google Scholar 

  36. Regan S, Egan KM, Hart L, Gragoudas ES. Color Doppler imaging of untreated and irradiated choroidal melanomas. Eur J Ophthalmol. 2001;11(2):150–5.

    CAS  PubMed  Google Scholar 

  37. Seddon JM, Gragoudas ES, Polivogianis L, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology. 1986;93(5):666–74.

    Article  CAS  PubMed  Google Scholar 

  38. Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology. 1987;94(4):354–61.

    Article  CAS  PubMed  Google Scholar 

  39. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999;106(8):1571–8.

    Article  CAS  PubMed  Google Scholar 

  40. Gragoudas ES, Lane AM. Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am. 2005;18(1):111–8.

    Article  PubMed  Google Scholar 

  41. Foss AJ, Whelehan I, Hungerford JL, et al. Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br J Ophthalmol. 1997;81(9):748–54.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol. 1995;119(2):157–64.

    CAS  PubMed  Google Scholar 

  43. Gragoudas ES. Charged particle irradiation of uveal melanoma. In: Ryan SJ, editor. Retina. 5th ed. London: Mosby; 2013.

    Google Scholar 

  44. Kim IK, Lane AM, Egan KM, Munzenrider J, Gragoudas ES. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010;117(8):1617–22.

    Article  PubMed  Google Scholar 

  45. Courdi A, Caujolle JP, Grange JD, et al. Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys. 1999;45(1):5–11.

    Article  CAS  PubMed  Google Scholar 

  46. Kodjikian L, Roy P, Rouberol F, et al. Survival after proton-beam irradiation of uveal melanomas. Am J Ophthalmol. 2004;137(6):1002–10.

    Article  CAS  PubMed  Google Scholar 

  47. Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010;128(7):871–5.

    Article  PubMed  Google Scholar 

  48. Gragoudas E, Egan K, Seddon J, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991;98(3):383–90.

    Article  CAS  PubMed  Google Scholar 

  49. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the MD Anderson Cancer Center experience and prognostic factors. Cancer. 1995;76(9):1665–70.

    Article  CAS  PubMed  Google Scholar 

  50. Eskelin S, Pyrhonen S, Hahka-Kemppinen M, Tuomaala S, Kivela T. A prognostic model and staging for metastatic uveal melanoma. Cancer. 2003;97(2):465–75.

    Article  PubMed  Google Scholar 

  51. Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK. Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol. 1998;21(6):568–72.

    Article  CAS  PubMed  Google Scholar 

  52. Alexander Jr HR, Libutti SK, Pingpank JF, et al. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res. 2003;9(17):6343–9.

    CAS  PubMed  Google Scholar 

  53. Agarwala SS, Panikkar R, Kirkwood JM. Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res. 2004;14(3):217–22.

    Article  CAS  PubMed  Google Scholar 

  54. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer. 2000;89(7):1561–8.

    Article  CAS  PubMed  Google Scholar 

  55. Hsueh EC, Essner R, Foshag LJ, Ye X, Wang HJ, Morton DL. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer. 2004;100(1):122–9.

    Article  PubMed  Google Scholar 

  56. Shields CL, Demirci H, Marr BP, et al. Intravitreal triamcinolone acetonide for acute radiation papillopathy. Retina. 2006;26(5):537–44.

    Article  PubMed  Google Scholar 

  57. Finger PT. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol. 2007;143(2):335–8.

    Article  CAS  PubMed  Google Scholar 

  58. Finger PT, Chin K. Anti-vascular endothelial growth factor bevacizumab (Avastin) for radiation retinopathy. Arch Ophthalmol. 2007;125(6):751–6.

    Article  CAS  PubMed  Google Scholar 

  59. Lane AM, Egan KM, Harmon D, et al. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009;116(11):2206–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Harvard Medical School, Boston, MA, USA

    Anne Marie Lane MPH, Ivana K. Kim MD & Evangelos S. Gragoudas MD

  2. Retina Service, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA, 02114, USA

    Anne Marie Lane MPH, Ivana K. Kim MD & Evangelos S. Gragoudas MD

Authors
  1. Anne Marie Lane MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ivana K. Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Evangelos S. Gragoudas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evangelos S. Gragoudas MD .

Editor information

Editors and Affiliations

  1. Ocular Oncology Service, Departments of Ophthalmology and Radiation Oncology, University of California, San Francisco, San Francisco, California, USA

    Bertil Damato

  2. Dept. of Ophthalmic Oncology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Arun D. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lane, A.M., Kim, I.K., Gragoudas, E.S. (2014). Uveal Malignant Melanoma – Management Options: Proton Beam Radiotherapy. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54255-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54255-8_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54254-1

  • Online ISBN: 978-3-642-54255-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation